van Daele M E, Berger R M, Smeets J, Hess J
Academisch Ziekenhuis Rotterdam-Sophia Kinderziekenhuis, afd. Kindercardiologie.
Ned Tijdschr Geneeskd. 1998 Jan 3;142(1):32-6.
A previously healthy boy aged 14 developed persistent ventricular tachycardia while engaged in sports; ultrasonography revealed arrhythmogenic right ventricular dysplasia (ARVD). He was treated with a class III antiarrhythmic drug but nevertheless died 4 years later during recreational activities. An uncle of the boy was found to have died suddenly on a playing field, 25 years previously at the age of 20. In ARVD, fibrolipomatous areas in the right ventricle lead to dilations of the wall where (sometimes fatal) re-entrant tachycardias may develop. An autosomal dominant heredity with variable expression and penetrance is considered probable, while the genetic defect was located recently. Examination and, if necessary, pharmacotherapy of relatives of an ARVD patient may reduce the risk of a fatal arrhythmia.
一名14岁的既往健康男孩在运动时出现持续性室性心动过速;超声心动图显示致心律失常性右室发育不良(ARVD)。他接受了III类抗心律失常药物治疗,但仍在4年后的娱乐活动中死亡。该男孩的一位叔叔在25年前20岁时在运动场上突然死亡。在ARVD中,右心室的纤维脂肪区域导致心室壁扩张,可能会发生(有时致命的)折返性心动过速。该病可能为常染色体显性遗传,具有可变的表达和外显率,而最近已确定其基因缺陷。对ARVD患者的亲属进行检查并在必要时进行药物治疗,可能会降低致命性心律失常的风险。